Gencor’s Levagen+ eases eczema symptoms, showing promising skin health benefits

21 Mar 2024 — Gencor’s latest human clinical trial showcases the efficacy of Levagen+ against eczema. The palmitoylethanolamide (PEA) ingredient is found to “significantly” alleviate dry, red, scaling and itchy skin when used as a topical cream. 

The provider of natural ingredients assessed the effectiveness of Levagen+ compared to a standard moisturizer in reducing eczema severity and enhancing patient outcomes.